PDCD1 and melanoma: A study of 71 MM patients showed that higher levels of circulating EVs predicted worse survival (PFS, OS, and ORR) in patients with MM, and high levels of PD-1 EVs in CD8+ T cells and PD-L1 EVs in melanoma cells were independent biomarkers for predicting PFS.